The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Human dendritic cell subsets: an update
Open accessAbstract
Dendritic cells (DC) are a class of bone-marrow-derived cells arising from lympho-myeloid haematopoiesis that form an essential interface between the innate sensing of pathogens and the activation of adaptive immunity. This task requires a wide range of mechanisms and responses, which are divided between three major DC subsets: plasmacytoid DC (pDC), myeloid/conventional DC1 (cDC1) and myeloid/conventional DC2 (cDC2). Each DC subset develops under the control of a specific repertoire of transcription factors involving differential levels of IRF8 and IRF4 in collaboration with PU.1, ID2, E2-2, ZEB2, KLF4, IKZF1 and BATF3. DC haematopoiesis is conserved between mammalian species and is distinct from monocyte development. Although monocytes can differentiate into DC, especially during inflammation, most quiescent tissues contain significant resident populations of DC lineage cells. An extended range of surface markers facilitates the identification of specific DC subsets although it remains difficult to dissociate cDC2 from monocyte-derived DC in some settings. Recent studies based on an increasing level of resolution of phenotype and gene expression have identified pre-DC in human blood and heterogeneity among cDC2. These advances facilitate the integration of mouse and human immunology, support efforts to unravel human DC function in vivo and continue to present new translational opportunities to medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The three other proteins increased in abundance in TET2-CH were CD1C (a marker of conventional dendritic cells), CLEC4C (a marker of plasmacytoid dendritic cells) and CD86 (a marker of dendritic cells, monocytes and other antigen-presenting cells)51.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [51]
Experimental — accuracy not yet measuredIn the citing paper
“pDCs are instead characterized by a marked impairment of cytokine release in older people (27, 29).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Simultaneous epitope and transcriptome measurement in single cells
Stoeckius, M., Hafemeister, C., Stephenson, W., Houck-Loomis, B., Chattopadhyay, P. K., Swerdlow, H., Satija, R., & Smibert, P. (2017) · Nature Methods · doi:10.1038/nmeth.4380 · Cited by 3,098
Nomenclature of monocytes and dendritic cells in blood
Ziegler‐Heitbrock, L., Ancuța, P., Crowe, S. M., Dalod, M., Grau, V., Hart, D. N. J., Leenen, P. J. M., Liu, Y.-J., MacPherson, G. G., Randolph, G. J., et al. (2010) · Blood · doi:10.1182/blood-2010-02-258558 · Cited by 2,436
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Villani, A.-C., Satija, R., Reynolds, G., Sarkizova, S., Shekhar, K., Fletcher, J., Griesbeck, M., Butler, A., Zheng, S., Lazo, S., et al. (2017) · Science · doi:10.1126/science.aah4573 · Cited by 2,413
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,229
Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
Liu, S., Cai, X., Wu, J., Cong, Q., Chen, X., Li, T., Du, F., Ren, J., Wu, Y.-T., Grishin, N. V., et al. (2015) · Science · doi:10.1126/science.aaa2630 · Cited by 1,927
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S. H., Onai, N., Schraml, B. U., Segura, É., Tussiwand, R., & Yona, S. (2014) · Nature reviews. Immunology · doi:10.1038/nri3712 · Cited by 1,923
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,734
Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D., & Schmitz, J. (2000) · Journal of Immunology · doi:10.4049/jimmunol.165.11.6037 · Cited by 1,433
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 998
Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
DeVito, N. C., Plebanek, M. P., Theivanthiran, B., & Hanks, B. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02876 · Cited by 105
Cancer vaccines: current status and future directions
Zhou, Y., Wei, Y., Tian, X., & Wei, X. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01670-w · Cited by 121
“Human DCs are primarily classified into CD123 + plasma-cytoid DCs (pDCs) and conventional DCs (cDCs), with cDCs further divided into CD141 + cDC1s and CD1c + cDC2s, which resemble mouse B220 + pDCs, CD8α + and/ or CD103 + cDC1s, and CD11b + cDC2s, respectively [50].”
The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity
Saito, Y., Komori, S., Kotani, T., Murata, Y., & Matozaki, T. (2022) · Cancers · doi:10.3390/cancers14081976 · Cited by 108
“Studies with SIRPαor CD47-deficient mice have shown that SIRPα is essential for homeostatic regulation of cDC2s in secondary lymphoid organs [104–106], and recent work suggested that chronic activation of the cDC2 subset was involved in such homeostatic regulation of the subset, at least in the spleen [107].”
BackgroundInfluentialMasenga, S. K., Mweene, B. C., Luwaya, E. L., Muchaili, L., Chona, M., & Kirabo, A. (2023) · Cells · doi:10.3390/cells12101351 · Cited by 114
Molecular mechanisms of dendritic cell migration in immunity and cancer
de Winde, C. M., Munday, C., & Acton, S. E. (2020) · Medical Microbiology and Immunology · doi:10.1007/s00430-020-00680-4 · Cited by 104
Le, J., Park, J. E., Ha, V. L., Luong, A., Branciamore, S., Rodin, A. S., Gogoshin, G., Li, F., Loh, Y. E., Camacho, V., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.010 · Cited by 91
“P2 showed very little expression of PAX5 (expressed in 7% of cells) and CD19 (5% of cells) (Figure 3B) and did not express the mature pDC markers NRP1 (Collin and Bigley, 2018) or CD4 (Schmitt et al.”
BackgroundSexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy
Capone, I., Marchetti, P., Ascierto, P. A., Malorni, W., & Gabriele, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00552 · Cited by 97
CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment
Lei, X., Khatri, I., de Wit, T., de Rink, I., Nieuwland, M., Kerkhoven, R. M., van Eenennaam, H., Sun, C., Garg, A. D., Borst, J. G., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35615-5 · Cited by 99
Kong, Y., Shao, Y. W., Ren, C., & Yang, G. S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02526-z · Cited by 94
Fang, Q., Stehr, A. M., Naschberger, E., Knopf, J., i, M. H., & Stürzl, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1075260 · Cited by 102
Vitamin D status and the immune assessment in 22q11.2 deletion syndrome
Legitimo, A., Bertini, V., Costagliola, G., Baroncelli, G. I., Morganti, R., Valetto, A., & Consolini, R. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13429 · Cited by 92
Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites
Chulanetra, M., & Chaicumpa, W. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.702125 · Cited by 99
“DCs are classified into three main groups: monocyte-derived DCs (mDCs), conventional DCs (cDCs, which can be further divided into cDC1/BDCA3/CD141, and cDC2/BDCA1/CD1c), and plasmacytoid DCs (pDCs) (Collin and Bigley, 2018).”
BackgroundCarenza, C., Calcaterra, F., Oriolo, F., Vito, C. D., Ubezio, M., Porta, M. G. D., Mavilio, D., & Bella, S. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01325 · Cited by 91
Affandi, A. J., Grabowska, J. A., Olesek, K., Venegas, M. L., Barbaria, A., Rodríguez, E., Mulder, P. P. G., Pijffers, H. J., Ambrosini, M., Kalay, H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006186117 · Cited by 90
“Both in mice and humans, DCs can be divided into several subsets, of which the conventional DCs (CD141 + cDC1 and CD1c + cDC2) have been shown to be responsible for T cell priming (12, 13).”
Xue, D., Tabib, T., Morse, C., Yang, Y., Domsic, R. T., Khanna, D., & Lafyatis, R. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41813 · Cited by 94
“In humans, mo-DCs are one of several myeloid cell types capable of crosspresentation (26).”
BackgroundZhang, R. M., McNerney, K. P., Riek, A. E., & Bernal‐Mizrachi, C. (2020) · Acta Physiologica · doi:10.1111/apha.13487 · Cited by 88
Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance
Castenmiller, C., Doungtsop, B.-C. K., van Ree, R., de Jong, E. C., & van Kooyk, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.643240 · Cited by 92
“However, recent findings providing evidence for a lymphoid origin of the majority of pDCs challenges this hypothesis (4, 13, 19, 20).”
BackgroundBalta, E., Wabnitz, G. H., & Samstag, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115736 · Cited by 88
Yi, L., Jiang, X., Zhou, Z., Xiong, W., Xue, F., Liu, Y., Xu, H., Fan, B., Li, Y., & Shen, J. (2024) · Advanced Materials · doi:10.1002/adma.202304328 · Cited by 92
Cancer vaccines and the future of immunotherapy
Pail, O., Lin, M. J., Anagnostou, T., Brown, B. D., & Brody, J. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00553-7 · Cited by 98
Novoszel, P., Holcmann, M., Stulnig, G., Fernandes, C. D. S., Zyulina, V., Borek, I., Linder, M., Bogusch, A., Drobits, B., BAUER, T. L., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012409 · Cited by 86
“While cDC1 promote Th 1 immunity, cDC2 drive Th 2 and Th 17 responses (Collin & Bigley, 2018).”
Zhang, J., Song, C., Tian, Y. F., & Yang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.802080 · Cited by 89
Han, P., Hanlon, D. J., Arshad, N., Lee, J. S., Tatsuno, K., Yurter, A., Robinson, E., Filler, R. B., Sobolev, O., Cote, C. M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz1580 · Cited by 85
Kai, H., Wang, C., Vagts, C. L., Raguveer, V., Finn, P. W., & Perkins, D. L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0261242 · Cited by 84
Psarras, A., Antanaviciute, A., Alase, A. A., Carr, I., Wittmann, M., Emery, P., Tsokos, G. C., & Vital, E. M. J. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.1901358 · Cited by 84
“BDCA-3 but, unlike pDCs, they demonstrate CD11c expression as cDCs (50, 51).”
BackgroundQu, X., Wang, Y., Jiang, Q., Ren, T., Guo, C., Hua, K., & Qiu, J. (2023) · 癌症:英文版 · doi:10.1002/cac2.12486 · Cited by 86
“We acquired 9 DC clusters by re-clustering and categorized them into the following 6 subsets according to marker gene expression [24] (Figure 2A-B, Supplementary Figure S2A): DC_CD207_CD1C ( CD207 and CD1C ), DC_CD1C ( CD1C, FCER1A, CLEC10A ), DC_CLEC9A ( CLEC9A, XCR1, CADM1 ), pDC ( LILRA4 ),…”
MethodKim, S. K., Bagadia, P., Anderson, D. A., Liu, T., Huang, X., Theisen, D. J., O’Connor, K., Ohara, R. A., Iwata, A., Murphy, T. L., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.018 · Cited by 86
Wang, D., Cui, Q., Yang, Y. J., Liu, A. Q., Zhang, G., & Yu, J. C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113541 · Cited by 82
Tumor-associated myeloid cells in cancer immunotherapy
Cheng, X., Wang, H., Wang, Z., Zhu, B., & Long, H. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01473-x · Cited by 76
“Tumor‐associated dendritic cell (TADC) TADC populations are composed of three major subgroups: plasmacytoid DC (pDC), conventional DC (cDC1 and cDC2), and monocyte-derived DC (moDC) [48].”
BackgroundLi, B., Wang, P., Jiao, J., Wei, H., Xu, W., & Zhou, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.824117 · Cited by 79
Peruzzi, B., Bencini, S., Capone, M., Mazzoni, A., Maggi, L., Salvati, L., Vanni, A., Orazzini, C., Nozzoli, C., Morettini, A., et al. (2020) · Immunology · doi:10.1111/imm.13254 · Cited by 72
Wu, H., Chen, L.-H., Hsu, L.-T., & Lai, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113382 · Cited by 77
Hatano, S., & Watanabe, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00232 · Cited by 72
Cafferata, E. A., Terraza‐Aguirre, C., Barrera, R., Alarcón, N. F., González, N., Rojas, C., Melgar‐Rodríguez, S., Hernández, M., Carvajal, P., Cortéz, C., et al. (2020) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13282 · Cited by 73
“Moreover, IL-35 favours the differentiation of naïve T cells into IL-35-producing Treg lymphocytes, a recently described cell population termed iTr35 that mediates immunosuppression mainly via IL-35 (Collin & Bigley, 2018; Collison et al., 2010).”
BackgroundHuman Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease
Caër, C., & Wick, M. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00410 · Cited by 76
Alterations in mitochondrial morphology as a key driver of immunity and host defence
Cervantes‐Silva, M. P., Cox, S. L., & Curtis, A. M. (2021) · EMBO Reports · doi:10.15252/embr.202153086 · Cited by 73
“In humans, there are two main subsets of DC: myeloid DCs (mDCs) participate in anti-bacterial and anti-fungal immune responses, while plasmacytoid (pDCs) are involved in anti-viral responses (Collin & Bigley, 2018).”
Li, X., Kolling, F., Aridgides, D. S., Mellinger, D., Ashare, A., & Jakubzick, C. (2022) · Life Science Alliance · doi:10.26508/lsa.202201458 · Cited by 76
“Using a curated gene list, we identified twelve major cell types (Complete list of genes: Table E1 and Figure 1B-1D) (17, 18, 26-35).”
MethodTranscriptional control of dendritic cell development and functions
Amon, L., Lehmann, C. H. K., Barańska, A., Schoen, J., Heger, L., & Dudziak, D. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.10.001 · Cited by 72
Immunophenotypic dissection of normal hematopoiesis
Órfão, A., Matarraz, S., Pérez‐Andrés, M., Almeida, J., Teodósio, C., Berkowska, M. A., & van Dongen, J. J. M. (2019) · Journal of Immunological Methods · doi:10.1016/j.jim.2019.112684 · Cited by 70
Papazoglou, A., Huang, M., Bulik, M., Lafyatis, A., Tabib, T., Morse, C., Sembrat, J., Rojas, M. M., Valenzi, E., & Lafyatis, R. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42286 · Cited by 73
“The DCs, which also originated almost entirely from the SSc-ILD lungs, clustered into a discrete cluster expressingCD1C (Figure 2C) and other markers of type 2 conventional dendritic cells (not shown) (26).”
BackgroundEnhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment
Belderbos, R. A., Aerts, J. G. J. V., & Vroman, H. H. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.03.007 · Cited by 67
“cDCs can be divided into twomain subtypes: cDC1 and cDC2.(48) cDC1s are superior in cross-presenting antigens and, thereby, inducing CD8 T cell activation.”
BackgroundGuttman‐Yassky, E., Zhou, L., & Krueger, J. G. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.03.021 · Cited by 69
Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia
Pastorczak, A. K., Domka, K., Fidyt, K., Poprzeczko, M., & Firczuk, M. (2021) · Cancers · doi:10.3390/cancers13071536 · Cited by 71
CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity
Affandi, A. J., Olesek, K., Grabowska, J. A., Twilhaar, M. K. N., Rodríguez, E., Saris, A., Zwart, E. S., Nossent, E. J., Kalay, H., de Kok, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.697840 · Cited by 68
Guo, K., Xiao, N., Liu, Y., Wang, Z., Tóth, J. S., Gyenis, J., Thakur, V. K., Oyane, A., & Shubhra, Q. T. H. (2021) · Nano Materials Science · doi:10.1016/j.nanoms.2021.12.001 · Cited by 67
Modulation of mTOR Signaling in Cardiovascular Disease to Target Acute and Chronic Inflammation
Kaldirim, M., Lang, A., Pfeiler, S., Fiegenbaum, P., Kelm, M., Bönner, F., & Gerdes, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.907348 · Cited by 69
Qiu, J., Qu, X., Wang, Y., Guo, C., Lv, B., Jiang, Q., Su, W., Wang, L., & Hua, K. (2023) · Advanced Science · doi:10.1002/advs.202204951 · Cited by 71
The Evolution, Immunopathogenesis and Biomarkers of Type 2 Inflammation in Common Allergic Disorders
Gao, Y., Wang, Z., Öğülür, İ., Li, S., Yazıcı, D., Li, X., Pat, Y., Zheng, Y., Babayev, H., Zeyneloglu, C., et al. (2025) · Allergy · doi:10.1111/all.16620 · Cited by 76
“In addition, there is another special type of DC, the monocyte-derived dendritic cell (mo-DC), which also participates in antigen presentation and has been proven to be locally recruited in the inflammatory tissues of AD and AR [100] (Figure 2).”
Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer
Chaib, M., Chauhan, S. C., & Makowski, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00351 · Cited by 65
“cDC1 depend on the transcription factors IRF8, Batf3, and ID2 for development and express CD103 in mice while CD141 is used to distinguish cDC1 in humans (Böttcher and Reis e Sousa, 2018; Collin and Bigley, 2018).”
BackgroundFunctional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications
Prete, A. D., Sozio, F., Barbazza, I., Salvi, V., Tiberio, L., Laffranchi, M., Gismondi, A., Bosisio, D., Schioppa, T., & Sozzani, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113930 · Cited by 69
“DC subsets are classified as conventional DCs (cDCs), plasmacytoid DCs (pDCs), and monocytederived DCs (moDCs) [6,7].”
BackgroundSchinke, C., Poos, A. M., Bauer, M., John, L., Johnson, S., Deshpande, S., Carrillo, L. F., Alapat, D. V., Rasche, L., Thanendrarajan, S., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007217 · Cited by 67
The immunopathogenesis of sarcoidosis
Miedema, J., Cinetto, F., Smed‐Sörensen, A., & Spagnolo, P. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103247 · Cited by 76
Peregrino, E. S., Castañeda‐Casimiro, J., Vázquez-Flores, L., Estrada-Parra, S. A., Baeza, C. W., Serafín‐López, J., & Wong‐Baeza, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116210 · Cited by 66
“The activation and maturation of DCs leads to increased expressions of MHC-II, CD80, and CD86, and mature DCs are producers of TNF α and IL-12 [165–167].”
BackgroundBlastic Plasmacytoid Dendritic Cell Neoplasm
Khoury, J. D. (2018) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-018-0489-z · Cited by 64
“[9] This is accomplished primarily through a tightly regulated toll-like receptor (TLR)7/9-MyD88-IRF7 pathway-mediated sensing of nucleic acid sequences and by functioning as antigen presenting cells in concert with other subsets of myeloid dendritic cells.”
BackgroundMassoth, L. R., Hung, Y. P., Ferry, J. A., Hasserjian, R. P., Nardi, V., Nielsen, G. P., Sadigh, S., Venkataraman, V., Selig, M. K., Friedmann, A. M., et al. (2021) · The Oncologist · doi:10.1002/onco.13801 · Cited by 67
SCITO-seq: single-cell combinatorial indexed cytometry sequencing
Hwang, B., Lee, D. S., Tamaki, W., Sun, Y., Ogorodnikov, A., Hartoularos, G. C., Winters, A. F., Yeung, B. Z., Nazor, K. L., Song, Y. S., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01222-3 · Cited by 65
Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking
Zhang, J., Supakorndej, T., Krambs, J. R., Rao, M., Abou‐Ezzi, G., Ye, R. Y., Li, S., Trinkaus, K. M., & Link, D. C. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124829 · Cited by 60
“Moreover, the majority of DCs in human bone marrow express CD1c but not CD141, and do not express CD45RA, consistent with a mature cDC2 phenotype (Figure 1G, and Supplemental Figure 1B) (20, 22).”
BackgroundDendritic Cell Vaccines in Ovarian Cancer
Zhang, X., He, T., Li, Y., Chen, L., Liu, H., Wu, Y., & Guo, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613773 · Cited by 65
“cDC1 is the main DC subtype that activates CD8 T cells through the antigen cross-presentation process (29), while cDC2 secretes IL10, IL-12, IL-23, and TNF-b to stimulate the differentiation of the CD4T cells (30).”
BackgroundRole of Innate Immunity in Allergic Contact Dermatitis: An Update
Yamaguchi, H. L., Yamaguchi, Y., & Peeva, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612975 · Cited by 70
“Mo-DCs are derived from blood monocytes and migrate into the tissue in the inflammatory state including skin sensitization.”
BackgroundInfluentialShirafkan, F., Hensel, L., & Rattay, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1339714 · Cited by 67
“Instead, cDC2s are de fi ned by their surface expression of CD11b and CD172a (SIRP a ), are developmentally dependent on IRF4, IRF2 and RelB, and preferentially activate CD4 + helper T cell responses (171, 172).”
BackgroundInnate Immunity and Synovitis: Key Players in Osteoarthritis Progression
Panichi, V., Costantini, S., Grasso, M., Arciola, C. R., & Dolzani, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212082 · Cited by 66
“On the other hand, cDC2s produce higher quantities of IL-12 and are potent activators of Th1, Th2, Th17, and CD8+ T cells [107,108].”
Dendritic Cells, the Double Agent in the War Against HIV-1
Martín-Moreno, A., & Muñoz‐Fernández, M. Á. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02485 · Cited by 69
IL-3 in the development and function of basophils
Varricchi, G., Poto, R., Marone, G., & Schroeder, J. T. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101510 · Cited by 63
Deubiquitinating enzyme OTUB1 in immunity and cancer: Good player or bad actor?
Liao, Y., Yang, M., Wang, K., Wang, Y., Zhong, B., & Jiang, N. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.002 · Cited by 63
Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus
Bolouri, N., Akhtari, M., Farhadi, E., Mansouri, R., Faezi, S. T., Jamshidi, A., & Mahmoudi, M. (2022) · Inflammation Research · doi:10.1007/s00011-022-01554-6 · Cited by 62
Glycolysis in Innate Immune Cells Contributes to Autoimmunity
Xu, Y., Chen, Y., Zhang, X., Ma, J., Liu, Y., Cui, L., & Wang, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.920029 · Cited by 64
The role of dendritic cells and their immunometabolism in rheumatoid arthritis
Suwa, Y., Nagafuchi, Y., Yamada, S., & Fujio, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161148 · Cited by 63
Gao, F., Peng, H., Gou, R., Zhou, Y., Ren, S., & Li, F. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00670-3 · Cited by 68
“DCs, particularly plasmacytoid DCs (pDCs) and myeloid DCs (mDCs), serve as a crucial link between NET immunogenicity and adaptive immune responses [117].”
Metabolic regulation of dendritic cell activation and immune function during inflammation
Wu, L., Yan, Z., Jiang, Y., Chen, Y., Du, J., Guo, L., Xu, J., Luo, Z., & Liu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1140749 · Cited by 62
Niveau, C., Cettour-Cave, M., Mouret, S., Cuevas, E. S., Pezet, M., Roubinet, B., Gil, H., de Fraipont, F., Landemarre, L., Charles, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56392-x · Cited by 58
Marzaioli, V., Canavan, M., Floudas, A., Wade, S. C., Low, C., Veale, D. J., & Fearon, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01406 · Cited by 57
A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses
Bozkus, C. C., Blazquez, A. B., Enokida, T., & Bhardwaj, N. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100758 · Cited by 57
“Furthermore, PBMCs include multiple antigenpresenting cell (APC) populations, such as monocytes and dendritic cells (DCs), including conventional (cDCs) and plasmacytoid (pDCs) subsets (Collin and Bigley, 2018).”
BackgroundImaging dendritic cell functions*
Bošnjak, B., Do, K. T. H., Förster, R., & Hammerschmidt, S. I. (2021) · Immunological Reviews · doi:10.1111/imr.13050 · Cited by 59
Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease
Dou, L., Ono, Y., Chen, Y.-F., Chen, X., & Thomson, A. W. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1646949 · Cited by 60
Hatscher, L., Lehmann, C. H. K., Purbojo, A., Onderka, C., Liang, C., Hartmann, A., Cesnjevar, R. A., Bruns, H., Groß, O., Nimmerjahn, F., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abe1757 · Cited by 60
Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
Campana, P., Parisi, V., Leosco, D., Bencivenga, D., Ragione, F. D., & Borriello, A. (2020) · Cells · doi:10.3390/cells9092046 · Cited by 55
Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
Ricci, D., Etna, M. P., Rizzo, F., Sandini, S., Severa, M., & Coccia, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137017 · Cited by 61
“Three DC subpopulations are present in the lung: conventional DC (cDC), including the CD141+ cDC1 population (mainly activating a Th1 response); the CD1c+ cDC2 population (responsible for regulation and production of pro-inflammatory chemokines); and CD123high pDC [86].”
BackgroundThe Importance of Metabolism for Immune Homeostasis in Allergic Diseases
Rodríguez‐Coira, J., Villaseñor, A., Izquierdo, E., Huang, M., Barker‐Tejeda, T. C., Radzikowska, U., Sokołowska, M., & Barber, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692004 · Cited by 58
Mariottoni, P. R. C. G. B., Jiang, S. W., Prestwood, C. A., Jain, V., Suwanpradid, J., Whitley, M. J., Coates, M., Brown, D. A., Erdmann, D., Corcoran, D. L., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.665873 · Cited by 53
““Classical” or “conventional” DCs (cDC) can be classified in two types: cDC1 and cDC2 (81).”
BackgroundInfluentialMorante-Palacios, O., Godoy‐Tena, G., Calafell-Segura, J., Ciudad, L., Martínez-Cáceres, E. M., Sardina, J. L., & Ballestar, E. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac941 · Cited by 57
“Furthermore, monocyte-derived DCs (moDCs) can be differentiated in vitro from monocytes (MOs), with GM-CSF and IL-4 (2). moDCs have been classically used as a convenient model that mimics blood DCs, especially cDC2 (3).”
MethodPatel, R. S., Tomlinson, J. E., Divers, T. J., de Walle, G. R. V., & Rosenberg, B. R. (2021) · BMC Biology · doi:10.1186/s12915-020-00947-5 · Cited by 54
“markers for cDC1 in humans and mice [30] (in mice, CLEC9A is also expressed on plasmacytoid DC [31]).”
BackgroundResultXue, D., Tabib, T., Morse, C., & Lafyatis, R. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.11.012 · Cited by 54
Codrici, E., Popescu, I. D., Tănase, C., & Enciu, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052509 · Cited by 62
“DCs are classified into three groups, according to their immunophenotypic profile: classical DCs (cDC) and plasmacytoid DCs (pDC), which are present and active under steady-state conditions and monocyte-derived DCs (moDC), which arise only during inflammation [122].”
BackgroundRecent Progress in Dendritic Cell-Based Cancer Immunotherapy
Matsuo, K., Yoshie, O., Kitahata, K., Kamei, M., Hara, Y., & Nakayama, T. (2021) · Cancers · doi:10.3390/cancers13102495 · Cited by 54
“Recent studies have shown that pDCs are specialized for viral infection and rapidly produce large amounts of type I and III IFNs by activation via TLRs, while they have poor antigen-presenting capacity to naive T cells [41,61].”
BackgroundInfluentialBaretti, M., Danilova, L., Durham, J. N., Betts, C. B., Cope, L., Sidiropoulos, D. N., Tandurella, J. A., Charmsaz, S., Groß, N., Hernandez, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52528-7 · Cited by 59
“…components, including pre-Dendritic Cell (preDC)/classic monocytes (Lin-CD14 + CD16 - ), which are early progenitors to mature dendritic cells, non-classical monocytes (Lin - CD14 low CD16 + ), early myelocytes, plasmacytoid dendritic cells (pDC) and classical dendritic cells (cDCs) 18,19 .”
Influentialvan Uden, D., Boomars, K. A., & Kool, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00011 · Cited by 53
“Under steady state conditions, several DC subsets with unique functions can be identified (40, 41).”
BackgroundAn immunologist’s guide to immunosenescence and its treatment
Caruso, C., Ligotti, M. E., Accardi, G., Aiello, A., & Candore, G. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2106217 · Cited by 53
Immune cellular components and signaling pathways in the tumor microenvironment
Yenyuwadee, S., Aliazis, K., Wang, Q., Christofides, A., Shah, R., Patsoukis, N., & Boussiotis, V. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.004 · Cited by 54
Infection, modulation and responses of antigen-presenting cells to African swine fever viruses
Franzoni, G., Giudici, S. D., & Oggiano, A. (2018) · Virus Research · doi:10.1016/j.virusres.2018.10.007 · Cited by 54
Molecular Aspects of Dendritic Cell Activation in Leishmaniasis: An Immunobiological View
Tibúrcio, R., Nunes, S., Nunes, I. V., Ampuero, M. R., Bonyek-Silva, Í., Lima, R., Tavares, N. M., & Brodskyn, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00227 · Cited by 53
“Interestingly, despite the significant importance of DCs in several immunological processes, these cells do not comprise a homogeneous population, and are further classified into distinct subtypes according to origin, differential expression of surface proteins, cell localization, and immunological function (15).”
BackgroundInfluentialCross-Presenting XCR1+ Dendritic Cells as Targets for Cancer Immunotherapy
Audsley, K. M., McDonnell, A. M., & Waithman, J. C. (2020) · Cells · doi:10.3390/cells9030565 · Cited by 54
Plesca, I., Müller, L., Böttcher, J. P., Medyouf, H., Wehner, R., & Schmitz, M. (2022) · European Journal of Immunology · doi:10.1002/eji.202149487 · Cited by 58
The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Xu, Y., Lan, P., & Wang, T. (2023) · Medicina · doi:10.3390/medicina59111984 · Cited by 58
“Two main types of mature DCs have been identified: plasmacytoid DCs (pDCs) and myeloid DCs (mDCs) [65].”
BackgroundDecidual immune cells: Guardians of human pregnancies
Solano, M. E. (2019) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2019.05.009 · Cited by 55
Plasmacytoid dendritic cells in the eye
Jamali, A., Kenyon, B. M., Ortiz, G., Abou-Slaybi, A., Sendra, V. G., Harris, D. L., & Hamrah, P. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100877 · Cited by 52
Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection
Chang, T., Yang, J., Deng, H., Chen, D., Yang, X., & Tang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843342 · Cited by 57
Polysialic Acid in the Immune System
Villanueva-Cabello, T. M., Gutiérrez-Valenzuela, L. D., Salinas-Marín, R., López-Guerrero, D. V., & Martínez-Duncker, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.823637 · Cited by 50
Peng, G., & Fadeel, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114422 · Cited by 54
Digitaldlsorter: Deep-Learning on scRNA-Seq to Deconvolute Gene Expression Data
Torroja, C., & Sánchez‐Cabo, F. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00978 · Cited by 52
“Clusters C2 and C11 were considered monocyte derived based on CD14, PTPRC and ITGAX expression (Collin and Bigley, 2018) ( Figure 3 , Supplementary Figures 6 and 9 ).”
Ejarque, R. A., Ale, H. B., Grys, K., Tosi, I., Solanky, S., Ainali, C., Catak, Z., Sreeneebus, H., Saklatvala, J. R., Dand, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25066-9 · Cited by 51
Metadata
- Authors
- Collin, M., & Bigley, V.
- Affiliations
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Collin, Matthew
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2018-02-27
- Volume
- 154
- Issue
- 1
- Pages
- 3-20
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- PMC
- PMC5904714
- OpenAlex
- W2781617771
- Cited by
- 1,301
- References
- 203
- Citations by year
- 2026: 69 · 2025: 169 · 2024: 167 · 2023: 191 · 2022: 237 · 2021: 198 · 2020: 155 · 2019: 87 · 2018: 27
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Cancer Research UK (C30484/A21025)
- Wellcome Trust (101155/Z/13/Z)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cells, dendritic cell subsets, plasmacytoid dendritic cells, myeloid dendritic cells, DC1, DC2, transcription factors, IRF8, IRF4, PU.1, monocyte-derived dendritic cells, cell surface markers, innate immunity, adaptive immunity
- MeSH terms
- Kruppel-Like Factor 4, Cell Communication, Cell Differentiation, Dendritic Cells, Humans, Immunity, Phenotype, Signal Transduction, Biomarkers, Immunophenotyping
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review